Stay updated on Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision tag for the study documents updated from v3.5.4 to v3.5.5. This reflects an updated version of the documents referenced on the page.
    Difference
    0.0%
    Check dated 2026-06-08T17:09:28.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    Publication details for a PubMed-listed article related to the study were added under Publications, including authors, title, journal, year, and DOI. A note explains that some entries are auto-filled from PubMed and may not be exclusively about the study.
    Difference
    0.2%
    Check dated 2026-05-25T08:53:45.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A new Revision: v3.5.4 appears on the page, replacing the previous Revision: v3.5.3. This update reflects a minor version change in the page's metadata rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-05-18T04:15:28.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page footer’s revision label has been updated from **v3.5.2** to **v3.5.3**, indicating a change to the site version rather than the study information.
    Difference
    0.0%
    Check dated 2026-04-26T13:33:48.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-19T04:48:20.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T08:42:52.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.